We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Blood Test for Predicting Childhood Diabetes Reconsidered

By HospiMedica International staff writers
Posted on 18 Mar 2011
The glycosalated hemoglobin (HbA1c) blood test is a rapid and convenient way of diagnosing diabetes.

The HbA1c test has become the preferred way to diagnose diabetes among the millions of patients who have the disease, but are asymptomatic. More...
The simple test measures longer-term blood sugar levels without requiring patients to fast overnight.

Scientists at the University of Michigan, (Ann Arbor, MI, USA), studied whether the assay could be used to make a diagnosis of diabetes mellitus in adolescents, using the standardized values for adults. For the study, they evaluated the testing results of 1,156 obese and overweight adolescents, aged 12-18 years. The American Diabetes Association, (Alexandria, VA, USA), recommends screening only obese and overweight children because their weight puts them at higher risk for developing diabetes.

Individuals were defined as having diabetes mellitus if their fasting plasma glucose (FPG) was equal to or greater than 126 mg/dL; a 2-hour plasma glucose (2-hr PG) equal to or greater than 200 mg/dL or were prediabetic where the FPG is between 100 and 126 mg/dL; and the 2-hr PG is between 140 and 200 mg/dL. According to the guidelines, individuals without symptoms would be classified as having diabetes if HbA1c values reach 6.5% and as having prediabetes if HbA1c values were between 6.0% and 6.4% on two separate tests.

Only four of the adolescents studied had undiagnosed diabetes mellitus. When assessing FPG to detect diabetes, an HbA1c of 6.5% had sensitivity rates of 75.0% for adolescents and 53.8% adults, although the specificity was higher. Additionally, when assessing FPG to detect diabetes mellitus, an HbA1c of 5.7% had sensitivity rates of 5.0% and 23.1%, and specificity rates of 98.3% and 91.1% for adolescents and adults, respectively. These analyses suggest that HbA1c is a poorer predictor of diabetes mellitus and prediabetes for adolescents compared with adults and performance was poor regardless of whether FPG or 2-hr PG measurements were used.

Joyce M. Lee, MD, MPH, a pediatric endocrinologist, and lead author of the study, said, "We found that hemoglobin A1c is not as reliable a test for identifying children with diabetes and prediabetes compared with adults and using this test in children may lead to missed cases." The study was published online ahead of print on December 30, 2010, in the Journal of Pediatrics.

Related Links:

University of Michigan

American Diabetes Association

Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Floor‑Mounted Digital X‑Ray System
MasteRad MX30+
ow Frequency Pulse Massager
ET10 L
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The fiber in the brain implant is less than half a millimeter thick (Photo courtesy of Peter Aagaard Brixen)

Brain Implant Records Neural Signals and Delivers Precise Medication

Neurological diseases such as epilepsy involve complex interactions across multiple layers of the brain, yet current implants can typically stimulate or record activity from only a single point.... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.